A genomic approach to predict synergistic combinations for breast cancer treatment
Soldi, R, Cohen, A L, Cheng, L, Sun, Y, Moos, P J, Bild, A H
Published in The pharmacogenomics journal (01.02.2013)
Published in The pharmacogenomics journal (01.02.2013)
Get full text
Journal Article
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Nevins, Joseph R, Bild, Andrea H, Yao, Guang, Chang, Jeffrey T, Wang, Quanli, Potti, Anil, Chasse, Dawn, Joshi, Mary-Beth, Harpole, David, Lancaster, Johnathan M, Berchuck, Andrew, Olson, John A, Marks, Jeffrey R, Dressman, Holly K, West, Mike
Published in Nature (19.01.2006)
Published in Nature (19.01.2006)
Get full text
Journal Article
Abstract SP012: Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine signaling inhibitors
Griffiths, JI, Chen, J, Cosgrove, PA, O'Dea, A, Sharma, P, Ma, CX, Trivedi, M, Kalinsky, K, Wisinski, KB, O'Reagan, R, Makhoul, I, Spring, LM, Bardia, A, Adler, FR, Cohen, AL, Chang, JT, Khan, QJ, Bild, AH
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage
BILD, Andrea H, MENDOZA, Francisco J, GIBSON, Erika M, MEI HUANG, VILLANUEVA, Jacylyn, GARRINGTON, Timothy P, JOVE, Richard, JOHNSON, Gary L, GIBSON, Spencer B
Published in Oncogene (26.09.2002)
Published in Oncogene (26.09.2002)
Get full text
Journal Article